Prospera Biotech
Innovative neurodermatological solutions to improve quality of life of cancer patients treated with chemotherapy
Status
IP Type
Patent
Time
–
Countries
Coverage
-WO2018206742 – TRPV1 MODULATOR COMPOUNDS. This is the patent protecting Calmapsin (AntalGenics) for which Prospera Biotech has a worldwide exclusive license for the use in topical formulations to alleviate CIPN symptoms in cancer patients.
Know more of this patent
Status
IP Type
Patent
Time
–
Countries
Coverage
EU patent application (EP22382149.7, 2022) protecting a neurodermatology formulation to reduce hyperhidrosis and its cutaneous impact.
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: Jan 20th 2023
KEEP REVIEWING